About Redcliffe Genetics
Redcliffe Genetics is a company based in Noida (India) founded in 2017 by Ashish Dubey, Dheeraj Jain, and Aditya Kandoi.. Redcliffe Genetics has raised $63.21 million across 5 funding rounds from investors including LeapFrog Investments, Schroders and HealthQuad. The company has 2,104 employees as of May 31, 2025. Redcliffe Genetics operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and deCODE Genetics, among others.
- Headquarter Noida, India
- Employees 2104 as on 31 May, 2025
- Founders Ashish Dubey, Dheeraj Jain, Aditya Kandoi
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$210.35 K (USD)-78as on Mar 31, 2024
-
Net Profit
$-1.31 M (USD)-14as on Mar 31, 2024
-
EBITDA
$-1.31 M (USD)-16as on Mar 31, 2024
-
Total Equity Funding
$63.21 M (USD)
in 5 rounds
-
Latest Funding Round
$61 M (USD), Series B
May 06, 2022
-
Investors
LeapFrog Investments
& 34 more
-
Employee Count
2104
as on May 31, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Redcliffe Genetics
Redcliffe Genetics has successfully raised a total of $63.21M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $61 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $61.0M
-
First Round
First Round
(08 Dec 2017)
- Investors Count 35
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Series B - Redcliffe Genetics | Valuation | LeapFrog Investments | |
| Feb, 2021 | Amount | Seed - Redcliffe Genetics | Valuation | IDG Ventures | |
| Jan, 2020 | Amount | Seed - Redcliffe Genetics | Valuation | Jai Drinks |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Redcliffe Genetics
Redcliffe Genetics has secured backing from 35 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include LeapFrog Investments, Schroders and HealthQuad. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on banking, finance, healthcare, and multiple sectors
|
Founded Year | Domain | Location | |
|
Healthcare investment fund focused on innovation and social impact in India.
|
Founded Year | Domain | Location | |
|
Seed-stage tech-focused VCl firm investing primarily in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Redcliffe Genetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Redcliffe Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Redcliffe Genetics Comparisons
Competitors of Redcliffe Genetics
Redcliffe Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and deCODE Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| domain | founded_year | HQ Location |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform for genetic disease analysis is provided.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing and genomics services are provided globally.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Redcliffe Genetics
Frequently Asked Questions about Redcliffe Genetics
When was Redcliffe Genetics founded?
Redcliffe Genetics was founded in 2017.
Where is Redcliffe Genetics located?
Redcliffe Genetics is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Is Redcliffe Genetics a funded company?
Redcliffe Genetics is a funded company, having raised a total of $63.21M across 5 funding rounds to date. The company's 1st funding round was a Seed of $632.7K, raised on Dec 08, 2017.
How many employees does Redcliffe Genetics have?
As of May 31, 2025, the latest employee count at Redcliffe Genetics is 2,104.
What is the annual revenue of Redcliffe Genetics?
Annual revenue of Redcliffe Genetics is $210.35K as on Mar 31, 2024.
What does Redcliffe Genetics do?
Redcliffe Genetics was established in 2017 in Noida, India, within the genetics and diagnostics sector. Products and services are delivered to research institutions, healthcare providers, and industry collaborators. High-throughput platforms, including MGI DNB-Seq and nanostring technologies, are integrated for sequencing applications. Offerings include whole genome sequencing, exome sequencing, amplicon sequencing, and molecular diagnostics targeting cytogenetics, rare genetic disorders, and infertility.
Who are the top competitors of Redcliffe Genetics?
Redcliffe Genetics's top competitors include Novogene Corporation, Source BioScience and Genewiz.
Who are Redcliffe Genetics's investors?
Redcliffe Genetics has 35 investors. Key investors include LeapFrog Investments, Schroders, HealthQuad, Alkemi Partners, and Jaipuria Group.
What is Redcliffe Genetics's valuation?
The valuation of Redcliffe Genetics is $1.82M as of Feb 2021.